Evidence map›Paper›PMID 34773475›Full record

ArticleWorld journal of urology2022

Annual nationwide analysis of costs and post-operative outcomes after radical prostatectomy according to the surgical approach (open, laparoscopic, and robotic).

Guillaume Ploussard, Annabelle Grabia, Eric Barret, Jean-Baptiste Beauval, Laurent Brureau, Gilles Créhange, Charles Dariane, Gaëlle Fiard, Gaëlle Fromont, Mathieu Gauthé and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Impact of intra-abdominal pressure with AirSealWorld journal of urology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 11 institutions in 3 countries.

Guillaume PloussardDepartment of Urology, La Croix du Sud Hôpital, 52, Chemin de Ribaute, 31130, Quint Fonsegrives, France. g.ploussard@gmail.com.ORCID http://orcid.org/0000-0002-6004-2152
Annabelle GrabiaDepartment of Public Health, PMSI, Ramsay Santé, Paris, France.
Eric BarretDepartment of Urology, Institut Mutualiste Montsouris, Paris, France.
Jean-Baptiste BeauvalDepartment of Urology, La Croix du Sud Hôpital, 52, Chemin de Ribaute, 31130, Quint Fonsegrives, France.
Laurent BrureauDepartment of Urology, CHU de Pointe-à-Pitre, University of Antilles, 97110, Pointe-à-Pitre, France.
Gilles CréhangeDepartment of Radiotherapy, Institut Curie, Paris, France.
Charles DarianeDepartment of Urology, Hôpital Européen Georges-Pompidou, APHP, Paris University-U1151 Inserm-INEM, Necker, Paris, France.
Gaëlle FiardDepartment of Urology, Grenoble Alpes University Hospital, Université Grenoble Alpes, CNRS, Grenoble INP, TIMC-IMAG, Grenoble, France.
Gaëlle FromontDepartment of Pathology, CHRU Tours, Tours, France.
Mathieu GauthéUMR 1153, Unité de Recherche Clinique en Économie de la Santé, CRESS METHODS INSERM, Paris, France.
Romain MathieuDepartment of Urology, CHU Rennes, Rennes, France.
Raphaële Renard-PennaAP-HP, Radiology, Pitie-Salpetriere Hospital, Sorbonne University, F-75013, Paris, France.
Guilhem RoubaudDepartment of Medical Oncology, Institut Bergonié, 33000, Bordeaux, France.
Alain RuffionService d'urologie Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
Paul SargosDepartment of Radiotherapy, Institut Bergonié, 33000, Bordeaux, France.
Morgan RouprêtAP-HP, Urology, GRC 5 Predictive Onco-Uro, Pitie-Salpetriere Hospital, Sorbonne University, 75013, Paris, France.
Charles-Edouard LequeuDepartment of Public Health, PMSI, Ramsay Santé, Paris, France.
CC-AFU, Cancerology Committee of the Association Française d’Urologie
Inserm · FRSorbonne Université · FRGénérale de Santé · FRInstitut Bergonié · FRCentre Hospitalier Universitaire de Tours · FRHôpital de la Croix-Rousse · FRHôpital Pontchaillou · FRInstitut Curie · FRInstitute Mutualiste Montsouris · FRInstitut polytechnique de Grenoble · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAnnual countrywide data are scarce when comparing surgical approaches in terms of hospital stay outcomes and costs for radical prostatectomy (RP). We aimed to assess the impact of surgical approach on post-operative outcomes and costs after RP by comparing open (ORP), laparoscopic (LRP), and robot-assisted (RARP) RP in the French healthcare system. PATIENTS AND

methodsData from all patients undergoing RP in France in 2020 were extracted from the central database of the national healthcare system. Primary endpoints were length of hospital stay (LOS including intensive care unit (ICU) stay if present), complications (estimated by severity index), hospital readmission rates (at 30 and 90 days), and direct costs of initial stay. RESULTS AND LIMITATIONS: A total of 19,018 RPs were performed consisting in ORP in 21.1%, LRP in 27.6%, and RARP in 51.3% of cases. RARP was associated with higher center volume (p < 0.001), lower complication rates (p < 0.001), shorter LOS (p < 0.001), and lower readmission rates (p = 0.004). RARP was associated with reduced direct stay costs (2286 euros) compared with ORP (4298 euros) and LRP (3101 euros). The main cost driver was length of stay. The main limitations were the lack of mid-term data, readmission details, and cost variations due to surgery system.

conclusionsThis nationwide analysis demonstrates the benefits of RARP in terms of post-operative short-term outcomes. Higher costs related to the robotic system appear to be balanced by patient care improvements and reduced direct costs due to shorter LOS.

Indexed as

LaparoscopyRoboticsRobotic Surgical ProceduresHumansMaleProstatectomyTreatment OutcomeComplicationCostLaparoscopyProstate cancerRadical prostatectomyReadmissionVolume

Identifiers

PMID34773475
OpenAlexW3213336206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.